About Us
Our mission is to empower people living with neuromuscular diseases to live longer, more independent lives.
Press Releases
-
Sep 12, 2023
-
Aug 28, 2023MDA Board approves 37 research grants totaling $8.4 million toward neuromuscular disease research to advance research discoveries and new therapy development in amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth disease (CMT), Duchenne muscular dyst
-
Aug 21, 2023
-
Aug 16, 2023Funds raised go towards accelerating research, advancing care, and advocating to empower families living with muscular dystrophy, ALS (aka Lou Gehrig’s disease) and related neuromuscular diseases.
-
Aug 15, 2023MDA to advance greater awareness of the organization’s mission with newly established role.
-
Aug 14, 2023After a successful 2022 Program, MDA again seeks to fund public policy and advocacy projects that will benefit the neuromuscular community.
Press Releases
-
Sep 12, 2023
-
Aug 28, 2023MDA Board approves 37 research grants totaling $8.4 million toward neuromuscular disease research to advance research discoveries and new therapy development in amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth disease (CMT), Duchenne muscular dyst
-
Aug 21, 2023
-
Aug 16, 2023Funds raised go towards accelerating research, advancing care, and advocating to empower families living with muscular dystrophy, ALS (aka Lou Gehrig’s disease) and related neuromuscular diseases.
-
Aug 15, 2023MDA to advance greater awareness of the organization’s mission with newly established role.
-
Aug 14, 2023After a successful 2022 Program, MDA again seeks to fund public policy and advocacy projects that will benefit the neuromuscular community.
